Dynamic Light Scattering for Protein Size and Aggregation Measurement

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

• Dynamic light scattering measures Brownian motion to derive particle hydrodynamic radius, but dust, bubbles, and sample aggregates dominate the signal and corrupt results.
• Filter samples, optimize concentration, and verify viscosity and refractive index before measurement to obtain reproducible size distributions.
• DLS reports intensity-weighted data that cannot resolve small populations in the presence of large particles, so confirm results with an orthogonal method.

At a Glance

Understanding Dynamic Light Scattering

Dynamic light scattering measures the time dependent fluctuations in scattered light intensity caused by particles undergoing Brownian motion in solution. A laser illuminates the sample and the scattered light is collected at a fixed angle, typically 90 or 173 degrees. The intensity fluctuations are processed through an autocorrelation function that describes how quickly the signal decorrelates. Faster decorrelation corresponds to smaller particles moving quickly, while slower decorrelation corresponds to larger particles moving slowly.

The autocorrelation function is fitted to extract a diffusion coefficient. The Stokes Einstein equation then converts the diffusion coefficient to a hydrodynamic radius. This radius represents the apparent size of a sphere that diffuses at the same rate as the particle being measured. For proteins, the hydrodynamic radius includes the protein itself plus any bound water or attached moieties, so it is not identical to the molecular weight or the radius of gyration obtained from structural methods.

The intensity of light scattered by a particle scales with the sixth power of its diameter. A particle that is ten times larger in diameter scatters one million times more light than a smaller particle at the same concentration. This strong size dependence means that a tiny number of large aggregates can dominate the measured signal even when the bulk of the sample is monomeric. This is the central challenge in DLS interpretation and the reason why the method is sensitive to contamination and aggregation.

DLS is a relative and indirect measurement. It does not provide an absolute molecular weight or a direct count of particles. The instrument reports an intensity weighted size distribution, which can be converted to volume and number weighted distributions only if the optical properties and refractive index of the particles are known. For proteins, the refractive index increment is often assumed, and this assumption introduces uncertainty into the conversion.

The technique is best suited for detecting the presence of aggregates, monitoring stability over time, and comparing relative sizes between samples. It is less suited for determining exact molecular masses or resolving closely spaced size populations. For those questions, size exclusion chromatography with multi angle light scattering or analytical ultracentrifugation provides more definitive answers.

Instrument Components and Measurement Geometry

A DLS instrument consists of a laser source, a sample cell, a detector, and a digital correlator. The laser provides a coherent monochromatic light source, usually in the red or near infrared range. The sample cell holds the protein solution and is positioned so that the scattered light reaches the detector at a defined angle. The detector converts the scattered photons into an electrical signal, and the correlator computes the autocorrelation function in real time.

The measurement geometry affects the range of particle sizes that can be measured reliably. Backscatter detection at 173 degrees is common because it reduces the path length of the laser through the sample, which minimizes multiple scattering in turbid solutions. Backscatter geometry also reduces the contribution of dust settling at the bottom of the cuvette. Forward scatter detection at 90 degrees is more sensitive to larger particles and is often used when the sample is clean and the concentration is low.

The sample cell material matters for protein measurements. Disposable plastic cuvettes are convenient but can adsorb protein onto their walls, which changes the effective concentration and introduces a slow drift in the measured size. Glass cuvettes are more inert but require thorough cleaning between samples. The cuvette must be free of scratches and fingerprints because surface defects scatter light and add a constant background that corrupts the autocorrelation function.

Sample preparation is the most important step in obtaining reliable DLS data. The protein solution should be filtered through a membrane with a pore size smaller than the expected aggregate size. A 0.02 micron filter removes most dust and large aggregates but may also remove some protein if the protein itself is large or if the filter membrane binds protein nonspecifically. A 0.1 micron filter is a common compromise for typical protein samples.

The sample must be free of bubbles. Bubbles scatter light strongly and produce a slow decaying autocorrelation function that appears as a very large particle. Degassing the sample by gentle centrifugation or by allowing it to stand after filtration reduces bubble formation. The sample should be equilibrated to the measurement temperature before the run because temperature affects viscosity and the diffusion coefficient.

Concentration and Buffer Conditions

Protein concentration has a direct effect on DLS data quality. At very low concentrations, the scattered light intensity is weak and the signal to noise ratio is poor. The autocorrelation function becomes noisy and the fitted size may vary widely between runs. At very high concentrations, multiple scattering occurs when light scattered by one particle is scattered again by another particle before reaching the detector. This produces an apparent size that is smaller than the true size because the effective path length is reduced.

The optimal concentration range depends on the instrument and the protein. A typical working range for a soluble protein is 0.5 to 5 milligrams per milliliter, but this range shifts depending on the molecular weight and the optical properties of the protein. The instrument software often provides a count rate indicator that helps you select a concentration that gives a stable signal without saturating the detector.

The buffer composition affects the measurement through viscosity and refractive index. The Stokes Einstein relation requires the viscosity of the solvent at the measurement temperature. If the buffer contains high concentrations of glycerol, sucrose, or other cosolvents, the viscosity is higher than water and the diffusion coefficient is lower. Using the viscosity of water when the sample is in a viscous buffer produces a calculated size that is too large.

The refractive index of the solvent also affects the scattering intensity and the conversion of the autocorrelation function. Most DLS instruments allow the user to enter the solvent refractive index and viscosity. These values must be accurate for the buffer being used. A mismatch between the entered and the actual solvent properties produces a systematic error in the reported size.

The protein itself can interact with the buffer components. High salt concentrations can screen electrostatic interactions and reduce repulsion between protein molecules, which promotes aggregation. Low salt concentrations can expose charged patches that cause the protein to associate. The buffer should be chosen to maintain the protein in a stable, monodisperse state. A buffer that causes the protein to aggregate will produce a DLS signal that reflects the aggregate population instead of the monomer.

Interpreting the Autocorrelation Function

The autocorrelation function is the raw output of the DLS measurement. It describes the degree of similarity between the scattered light intensity at time zero and the intensity at a later time. For a monodisperse sample, the autocorrelation function decays exponentially with a single decay rate. For a polydisperse sample, the function decays as a sum of exponentials with different decay rates.

The decay rate is related to the diffusion coefficient. A fast decay corresponds to a high diffusion coefficient and a small particle. A slow decay corresponds to a low diffusion coefficient and a large particle. The instrument software fits the autocorrelation function to a model and extracts the distribution of decay rates, which is then converted to a size distribution.

The most common fitting method is the cumulant analysis, which fits the autocorrelation function to a polynomial. The first cumulant gives the average decay rate and the second cumulant gives the polydispersity index. The polydispersity index is a measure of the width of the size distribution. A value below 0.1 indicates a monodisperse sample, while a value above 0.3 indicates a broad distribution that may contain multiple populations.

The cumulant analysis is valid only for a single exponential decay, which corresponds to a monodisperse sample. When the sample contains multiple populations, the cumulant fit is an approximation and the reported average size is a weighted average that is biased toward the larger particles. The software may also provide a distribution analysis using a non-negative least squares or a CONTIN algorithm, which attempts to resolve multiple peaks.

The intensity weighted size distribution is the default output. This distribution is heavily weighted toward the largest particles because of the sixth power dependence of scattering intensity on size. A sample that is 99 percent monomer and 1 percent aggregate by mass will show a size distribution that appears to be dominated by the aggregate. The volume and number weighted distributions can be calculated, but these conversions require the refractive index and the density of the particle, which are not always known.

Common Sources of Error

Dust and particulate contamination is the most common source of error in DLS. Dust particles are typically larger than the protein and scatter light intensely. A single dust particle in the measurement volume can produce a slow decay component in the autocorrelation function that appears as a large particle. The measured size distribution will show a peak at a few micrometers even when the protein is monomeric.

Bubbles are another common contaminant. Bubbles can form when the sample is pipetted, when the cuvette is filled, or when the sample is warmed. A bubble has a very different refractive index from the solution and scatters light strongly. The autocorrelation function from a bubble is slow and appears as a very large particle. The bubble can also move within the cuvette, which produces a non-stationary signal that corrupts the measurement.

Protein aggregation is the most important biological source of error. Aggregates form when the protein is unstable, when the buffer conditions are unfavorable, or when the protein is subjected to stress such as freezing, thawing, or agitation. The aggregates can be small dimers or trimers, or they can be large insoluble particles. The presence of aggregates is often the reason the researcher is performing the DLS measurement, but the aggregates also interfere with the measurement of the monomer.

The sample can also contain non-protein contaminants such as lipids, nucleic acids, or cell debris. These contaminants scatter light and contribute to the measured size distribution. The contaminants may be present in the sample from the purification process or may be introduced during sample handling.

Viscosity and Refractive Index Mismatch

The Stokes Einstein relation requires the solvent viscosity at the measurement temperature. The viscosity of water is well known, but the viscosity of a buffer containing glycerol, sucrose, or other additives is different. The instrument software typically has a table of common solvents, but the user must select the correct solvent or enter the viscosity manually.

The viscosity of the buffer changes with temperature. The instrument should be set to the same temperature as the sample, and the viscosity should be entered for that temperature. A temperature mismatch between the sample and the instrument produces a systematic error in the diffusion coefficient and the calculated size.

The refractive index of the buffer affects the scattering intensity and the conversion of the measured intensity to a size distribution. The refractive index of water is 1.33, but the refractive index of a buffer containing high concentrations of salt or organic solvent is different. The instrument software uses the refractive index to calculate the scattering vector and the size. A mismatch between the entered and actual refractive index produces a systematic error.

The filtering step can also introduce error. A filter with a pore size that is too large allows dust and aggregates to pass through. A filter with a pore size that is too small can remove the protein or cause the protein to aggregate on the membrane surface. The filter should be chosen based on the size of the protein and the expected aggregate size.

Multiple Scattering and Concentration Effects

Multiple scattering occurs when the scattered light from one particle is scattered by another particle before reaching the detector. This effect is more pronounced at high concentrations and in forward scatter geometry. Multiple scattering reduces the apparent size because the effective path length is shorter and the diffusion coefficient appears larger.

The instrument can be configured to reduce multiple scattering. Backscatter geometry reduces the path length and is less sensitive to multiple scattering. The sample can also be diluted to reduce the concentration. The dilution should be performed with the same buffer to avoid changing the solvent conditions.

The concentration of the protein also affects the diffusion coefficient through interparticle interactions. At high concentrations, the protein molecules interact with each other and the diffusion coefficient is not the same as the diffusion coefficient at infinite dilution. The measured size is an apparent size that depends on the concentration. The concentration should be low enough that the interactions are negligible.

The optimal concentration can be determined by measuring the size at several concentrations and plotting the size versus concentration. The size should be constant in the concentration range where the interactions are negligible. The plateau region of this plot is the concentration range that gives the most reliable size measurement.

Temperature Control and Equilibration

The temperature of the sample affects the viscosity and the diffusion coefficient. The instrument should be set to a temperature that is appropriate for the protein and the buffer. The sample should be equilibrated to the temperature before the measurement. A sample that is not equilibrated will have a temperature gradient that produces a non-uniform viscosity and a distorted autocorrelation function.

The temperature should be stable during the measurement. A temperature drift causes the viscosity to change during the measurement, which produces a systematic error in the diffusion coefficient. The instrument should be allowed to reach a stable temperature before the measurement is started.

The temperature also affects the protein stability. A protein that is unstable at the measurement temperature will aggregate during the measurement, producing a time dependent size. The measurement should be performed at a temperature where the protein is stable. The stability can be assessed by measuring the size at several time points and checking for a change.

Data Quality Indicators

The instrument software provides several indicators of data quality. The count rate is the number of photons detected per second. A stable count rate indicates that the sample is not changing during the measurement. A count rate that drifts upward indicates that the protein is aggregating or that dust is settling into the measurement volume. A count rate that drifts downward indicates that the protein is adsorbing to the cuvette wall or that the sample is being photobleached.

The polydispersity index is a measure of the width of the size distribution. A low polydispersity index indicates a narrow distribution, which is expected for a pure monomeric protein. A high polydispersity index indicates a broad distribution, which may be due to aggregates or to a mixture of protein states.

The autocorrelation function should decay smoothly to the baseline. A noisy autocorrelation function indicates a low signal to noise ratio, which can be caused by a low concentration or by a dirty cuvette. The baseline should be stable and should not show a slow drift.

The instrument software may provide a quality report that indicates whether the measurement is acceptable. The report may include the count rate, the polydispersity index, and the baseline. The report should be reviewed before the size is accepted.

Common Failure Patterns and Troubleshooting

Practical Workflow for Reliable DLS Measurements

The first step is to prepare a clean sample. The protein should be in a buffer that is compatible with the protein and with the DLS instrument. The buffer should be filtered to remove dust and aggregates. The protein should be filtered to remove aggregates, but the filter should be chosen to avoid removing the protein.

The second step is to determine the optimal concentration. The concentration should be high enough to give a stable count rate but low enough to avoid multiple scattering. The concentration can be determined by measuring the count rate at a range of concentrations and selecting the concentration that gives a stable count rate.

The third step is to set the instrument parameters. The temperature should be set to the measurement temperature and the sample should be equilibrated. The solvent viscosity and refractive index should be entered for the buffer and the temperature. The measurement angle should be set to the backscatter geometry to reduce multiple scattering.

The fourth step is to perform the measurement. The sample should be placed in the cuvette and the measurement should be started. The count rate should be monitored during the measurement. The measurement should be repeated several times to confirm the reproducibility.

The fifth step is to interpret the data. The autocorrelation function should be reviewed for quality. The cumulant analysis should be used for a monodisperse sample. The distribution analysis should be used for a polydisperse sample. The size should be reported with the polydispersity index and the count rate.

Records and Measurements

The DLS measurement should be recorded with the following information: the sample name, the buffer composition, the protein concentration, the temperature, the solvent viscosity, the solvent refractive index, the measurement angle, the count rate, the polydispersity index, and the hydrodynamic diameter. The autocorrelation function and the size distribution should be saved for each measurement.

The records should be stored in a laboratory notebook or an electronic data system. The records should be traceable to the sample and the measurement conditions. The records should be reviewed by a second person to confirm the data quality.

The measurement should be repeated at least three times to confirm the reproducibility. The mean and the standard deviation of the size should be reported. The standard deviation should be small relative to the mean for a reliable measurement.

Quality Control and Validation

The DLS instrument should be calibrated with a standard particle of known size. The standard particle should be measured under the same conditions as the sample. The measured size should be within the expected range for the standard. The calibration should be performed regularly to confirm the instrument is working correctly.

The instrument should be validated with a protein of known size. The protein should be a well characterized protein with a known hydrodynamic diameter. The measured size should be compared to the expected size. The validation should be performed when the instrument is first set up and when the instrument is serviced.

The sample should be checked for the presence of aggregates by an orthogonal method. Size exclusion chromatography is a common method for detecting aggregates. The chromatography should be performed on the same sample that is measured by DLS. The results should be compared to confirm the DLS measurement.

Limitations of DLS

DLS is not a high resolution method. It cannot resolve two populations that are close in size. The resolution is typically limited to a factor of two to three in size. Two populations that differ by less than this factor will appear as a single broad peak.

DLS is not a quantitative method for the concentration of the aggregate. The intensity weighted distribution is biased toward the large particles, so the aggregate peak appears larger than the actual mass fraction. The volume and number weighted distributions can be calculated, but the conversion requires the refractive index and the mass of the particles.

DLS is not a method for determining the molecular weight of a protein. The hydrodynamic diameter is related to the molecular weight, but the relationship depends on the shape of the protein. A rod shaped protein has a larger hydrodynamic diameter than a globular protein of the same molecular weight. The molecular weight can be estimated from the hydrodynamic diameter, but the estimate is approximate.

DLS is not a method for determining the shape of the protein. The hydrodynamic diameter is the size of a sphere that diffuses at the same rate as the protein. The shape of the protein is not directly measured. The shape can be inferred from the comparison of the hydrodynamic diameter with the molecular weight, but the inference is not definitive.

Comparison with Other Protein Characterization Methods

Size exclusion chromatography with multi angle light scattering provides a direct measurement of the molecular weight of the protein and the aggregate. The chromatography separates the protein by size and the light scattering measures the molecular weight of each peak. This method is more accurate than DLS for determining the molecular weight and the aggregate content.

Analytical ultracentrifugation provides a direct measurement of the sedimentation coefficient and the molecular weight. The method is more accurate than DLS for the characterization of the protein and the aggregate. The method requires a specialized instrument and is more time consuming than DLS.

Dynamic light scattering is a faster and simpler method than the other methods. The measurement takes a few minutes and the instrument is relatively inexpensive. The method is suitable for the screening of the protein stability and the detection of the aggregate. The method is not suitable for the accurate determination of the molecular weight.

Biosafety and Regulatory Context

The protein samples measured by DLS may be derived from recombinant or synthetic nucleic acid molecules. The handling of these samples is subject to the NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules. The guidelines require the institution to establish a biosafety committee and to review the research for the risk. The researcher should confirm that the sample is handled under the appropriate containment level.

The protein samples may be infectious or toxic. The handling of these samples is subject to the Biosafety in Microbiological and Biomedical Laboratories guidelines. The guidelines require the laboratory to perform a risk assessment and to use the appropriate containment and personal protective equipment. The researcher should follow the institutional biosafety procedures.

The DLS instrument is a laser instrument. The laser can cause eye damage if the beam is viewed directly. The instrument should be operated with the safety interlock in place. The researcher should not look into the laser beam and should not open the instrument while the laser is on.

Professional Escalation Criteria

The researcher should escalate the measurement to a more experienced person when the DLS data are not reproducible. The researcher should escalate when the size is outside the expected range and the cause is not identified. The researcher should escalate when the polydispersity index is high and the distribution analysis does not resolve the populations.

The researcher should escalate when the sample is not stable and the size changes over time. The researcher should escalate when the protein is aggregating and the aggregation cannot be prevented by the buffer or the temperature. The researcher should escalate when the DLS data are needed for a regulatory submission or a publication.

The researcher should consult the NIST Laboratory Programs for the measurement standards and the calibration of the instrument. The researcher should consult the Molecular Biology and Laboratory Methods for the laboratory methods and the protocols. The researcher should consult the Addgene Protocols for the protein expression and the purification workflow.

Decision Framework for Triage of DLS Measurements

A practical triage framework helps you decide whether a DLS result is trustworthy, correctable, or requires a different method. The framework below uses three decision gates that follow the natural sequence of a measurement: sample quality, instrument settings, and data interpretation. Each gate has explicit pass and fail criteria that you can apply before you accept or reject a result.

Gate 1: Sample Quality Assessment

The first gate determines whether the sample itself is suitable for DLS. Start with the count rate reported by the instrument. A stable count rate between 100 and 500 kilocounts per second is typical for a soluble protein in the 0.5 to 5 milligram per milliliter range. A count rate below 50 kilocounts per second indicates the concentration is too low for a reliable autocorrelation function. A count rate above 1,000 kilocounts per second suggests the sample is too concentrated or contains large contaminants that dominate the scattering.

The attenuation setting is a second indicator. If the instrument requires maximum attenuation to avoid detector saturation, the sample is likely too turbid or too concentrated. If the instrument uses minimum attenuation and the count rate is still low, the sample is too dilute. Record both the attenuation setting and the count rate for every measurement.

The third indicator is the baseline of the autocorrelation function. The baseline should be flat and stable at the expected value of 1.0. A baseline that drifts upward or downward during the acquisition indicates a non-stationary signal, which can be caused by settling particles, bubbles, or protein adsorption to the cuvette wall. A non-stationary signal cannot be corrected by data processing and requires a fresh sample.

Gate 2: Instrument Parameter Verification

The second gate verifies that the instrument parameters match the actual sample conditions. The solvent viscosity and refractive index must be entered for the exact buffer composition and measurement temperature. A buffer containing 10 percent glycerol has a viscosity approximately 1.3 times that of water at 20 degrees Celsius. If you enter the viscosity of water for a glycerol containing buffer, the calculated hydrodynamic diameter will be approximately 30 percent too large.

The measurement temperature must match the temperature used to determine the viscosity. The viscosity of water changes by about 2 percent per degree Celsius near room temperature. A temperature mismatch of 2 degrees Celsius produces a systematic error of approximately 4 percent in the calculated size.

The measurement angle should be recorded and kept consistent for comparative studies. Backscatter geometry at 173 degrees is preferred for turbid samples and for samples with a tendency to aggregate. Forward scatter at 90 degrees is more sensitive to large particles but is more susceptible to multiple scattering. If you change the measurement angle between experiments, the results are not directly comparable.

Gate 3: Data Quality and Reproducibility Assessment

The third gate evaluates the quality of the autocorrelation function and the reproducibility of the size result. The autocorrelation function should decay smoothly from the intercept to the baseline without oscillations or discontinuities. A noisy decay indicates a low signal to noise ratio, which requires a higher concentration or a longer acquisition time.

The polydispersity index from the cumulant analysis should be below 0.1 for a monodisperse protein sample. A polydispersity index between 0.1 and 0.3 indicates a moderately broad distribution that may contain a small fraction of aggregates. A polydispersity index above 0.3 indicates a broad distribution that is not suitable for cumulant analysis and requires a distribution analysis or an orthogonal method.

The reproducibility criterion is a coefficient of variation below 10 percent across at least three replicate measurements. The coefficient of variation is the standard deviation divided by the mean, expressed as a percentage. If the coefficient of variation exceeds 10 percent, the measurement is not reproducible and the cause must be identified before the result is accepted.

Decision Matrix for Common Scenarios

Escalation Criteria for the Triage System

The triage system includes explicit escalation criteria for results that cannot be corrected by sample preparation or parameter adjustment. Escalate to a more experienced researcher or to a different method when any of the following conditions are present.

The first escalation condition is a polydispersity index above 0.3 that persists after filtration and concentration adjustment. This condition indicates a complex mixture that DLS cannot resolve. Size exclusion chromatography with multi angle light scattering is the appropriate next step because it separates the populations and measures the molecular weight of each peak.

The second escalation condition is a size that changes by more than 10 percent across replicate measurements after the viscosity and refractive index have been verified. This condition indicates an unstable sample or an instrument problem that requires investigation.

The third escalation condition is a size that is consistently outside the expected range for the protein by more than 20 percent. This condition may indicate that the protein is aggregated, that the buffer is incorrect, or that the protein has an unexpected shape. The result should be confirmed with an orthogonal method before any conclusion is drawn.

The fourth escalation condition is when the DLS data are needed for a regulatory submission or a publication. The data should be reviewed by a second person and confirmed with an independent method. The NIST Laboratory Programs provide guidance on measurement standards and calibration that are relevant to this review.

Record Keeping for the Triage Decision

Each triage decision should be recorded with the following information: the sample name, the buffer composition, the protein concentration, the temperature, the count rate, the attenuation setting, the polydispersity index, the hydrodynamic diameter, and the triage outcome. The outcome should be one of the following: accepted, repeated after correction, or escalated to another method.

The records should include the specific correction that was applied when a measurement was repeated. For example, the record should state that the sample was filtered through a 0.02 micron membrane or that the viscosity was changed from water to the buffer value. This information is essential for reproducing the measurement and for identifying systematic errors.

The records should be reviewed periodically to identify patterns. A pattern of size increases across multiple samples may indicate a buffer problem or a protein stability issue. A pattern of high polydispersity indices may indicate a purification problem. The review of the records is a quality control step that improves the reliability of future measurements.

Integration with the Practical Workflow

The triage framework is applied at each step of the practical workflow. The sample quality assessment is performed after the sample is prepared and before the instrument parameters are set. The parameter verification is performed before the measurement is started. The data quality assessment is performed after the measurement is complete.

The triage framework does not replace the practical workflow. It adds a decision layer that tells you whether to accept, repeat, or escalate each measurement. The framework is most useful when you are measuring many samples in a single session or when you are comparing results across different days or different instruments.

The framework is also useful for training new researchers. A new researcher can use the decision matrix to determine whether a measurement is acceptable without needing to interpret the autocorrelation function in detail. The explicit pass criteria reduce the subjectivity of the data quality assessment and improve the consistency of the results.

Limitations of the Triage Framework

The triage framework does not correct for all sources of error. It does not address the problem of protein shape, which affects the relationship between the hydrodynamic diameter and the molecular weight. It does not address the problem of the refractive index increment, which is assumed for the conversion of the intensity distribution to the volume and number distributions.

The framework does not replace the need for a well characterized protein standard. The instrument should be calibrated with a standard particle of known size, and the calibration should be verified with a protein of known hydrodynamic diameter. The calibration records should be maintained and reviewed as part of the quality control program.

The framework is a practical tool for the laboratory, not a substitute for the judgment of an experienced researcher. The pass criteria are typical values that may need to be adjusted for the specific instrument and the specific protein. The framework should be adapted to the local conditions and the local quality requirements.

Application to Comparative Studies

The triage framework is particularly useful for comparative studies where the goal is to detect a change in the size or the aggregation state of the protein. In a comparative study, the measurement conditions must be identical across all samples. The triage framework ensures that the conditions are verified before each measurement and that the results are reproducible.

For a comparative study, the triage decision should be recorded for each sample. The results should be reported as the mean and the standard deviation of the replicate measurements. The comparison should be based on the mean values and the confidence intervals, not on the individual measurements.

The triage framework also helps to identify the cause of a difference between samples. If one sample has a higher polydispersity index than the others, the triage framework directs you to check the sample quality and the instrument parameters before you attribute the difference to the protein. This reduces the risk of a false conclusion based on a measurement artifact.

Frequently Asked Questions

Why does my DLS measurement show a large size even though the protein is pure?

The large size is likely due to a small number of large particles such as dust, bubbles, or aggregates. The intensity of the scattered light scales with the sixth power of the size, so a tiny amount of large particles dominates the signal. Filter the sample through a 0.02 or 0.1 micron filter and degas the sample before the measurement.

How do I choose the right concentration for a DLS measurement?

The concentration should give a stable count rate without multiple scattering. A typical range is 0.5 to 5 milligrams per milliliter for a soluble protein. Measure the size at several concentrations and find the plateau where the size does not change with the concentration.

What is the polydispersity index and what does it mean?

The polydispersity index is a measure of the width of the size distribution. A value below 0.1 indicates a monodisperse sample. A value above 0.3 indicates a broad distribution that may contain multiple populations or aggregates. The polydispersity index is calculated from the cumulant analysis of the autocorrelation function.

Why is the size different when I use a different buffer?

The buffer affects the viscosity and the refractive index of the solvent. The Stokes Einstein relation uses the viscosity to calculate the size. A buffer with a higher viscosity produces a larger calculated size if the viscosity is not entered correctly. The buffer can also affect the protein stability and the aggregation state.

How do I know if my sample is aggregating during the measurement?

The count rate and the size should be stable over time. If the count rate increases or the size increases with each run, the protein is aggregating. Filter the sample, reduce the measurement time, or change the buffer to a condition that stabilizes the protein.

Can DLS determine the molecular weight of a protein?

DLS measures the hydrodynamic diameter, which is related to the molecular weight but not directly. The molecular weight can be estimated from the hydrodynamic diameter, but the estimate depends on the shape of the protein. Size exclusion chromatography with multi angle light scattering provides a more accurate molecular weight.

What is the difference between the intensity, volume, and number weighted distributions?

The intensity weighted distribution is the default output and is biased toward the largest particles. The volume and number weighted distributions are calculated from the intensity distribution using the optical properties of the particle. The conversion is not reliable for proteins because the refractive index and the mass of the particle are not known.

When should I use a different method instead of DLS?

Use a different method when the DLS data are not reproducible or when the size distribution is broad. Size exclusion chromatography with multi angle light scattering provides a more accurate molecular weight and aggregate content. Analytical ultracentrifugation provides a more accurate characterization of the protein and the aggregate.

Related Molecular Biology Guides

• Protein Expression and Purification: A Practical Guide
• Automated Protein Quantification: Methods and Applications
• Protein Crystallization: Principles, Methods, and Applications
• Protein Quality Assessment: Methods and Applications
• Protein Quantification Mass Spectrometry: A Practical Guide

References and Further Reading

• Molecular Biology and Laboratory Methods. National Library of Medicine.
• Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
• NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules. National Institutes of Health.
• Addgene Protocols. Addgene.
• MIQE Guidelines. Clinical Chemistry.
• NIST Laboratory Programs. National Institute of Standards and Technology.
• Protein analysis by dynamic light scattering: methods and techniques for students.. Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology, 2012.
• Measuring Nonspecific Protein-Protein Interactions by Dynamic Light Scattering.. Methods in molecular biology (Clifton, N.J.), 2019.
• Ultrasensitive dynamic light scattering immunodetection of alpha-fetoprotein using heptamer-amplified nanoparticle crosslinking aggregation.. Mikrochimica acta, 2024.
• DNA sensing based on aggregation of Janus particles using dynamic light scattering.. Analytica chimica acta, 2024.
• Zika Virus NS1 Protein Detection Using Gold Nanoparticle-Assisted Dynamic Light Scattering.. Chemistry, an Asian journal, 2024.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.